Replies to post #1886 on Ocera Therapeutics fka OCRX

[DewDiligence]

I'm moderately bullish as a position to hold into late 2016 (or longer). I think the STOP-HE trial has a fairly good chance to work out, and the current EV is so low that various things are capable of causing a big gain during the next 12-18 months.

OCRX is not a good trading stock, however, due to the low volume.